DAWEX
The French data exchange tech company Dawex, the German research organization Fraunhofer ISST and the Dutch research organization TNO, today announced they have reached an agreement to co-propose a workshop program from the European Committee for Standardization (CEN) on Trusted Data Transaction, initiating a standardization process.
To tackle economic, environmental and societal challenges, public and private organizations, large corporations and SMBs are taking full advantage of the explosion of data, and are increasingly distributing, accessing and sharing data within emerging data ecosystems. Data transactions are expected to grow exponentially in the coming years, requiring clear frameworks to organize, simplify, and secure the exchange of data, in compliance with regulatory requirements. Trust is a cornerstone of data exchange as it cements the relationship and drives collaboration between all parties involved in the data transactions.
To better understand the scope and implications of the expression of “Trusted Data Transaction” and anticipate future associated standardization requirements, a European Committee for Standardization (CEN) workshop program is being kicked off. Among its objectives are to develop terminologies, concepts, and mechanisms for common elements, starting with the groundwork on trust anchors, in order to form a foundational understanding on which trusted data transactions can be based, independent of any architectural choices or technical implementation.
Organizations interested in joining the program can express their interest by registering here, while CEN officializes the meeting schedule and kickoff time frame.
“The agreement to co-propose a European Committee for Standardization workshop program on Trusted Data Transaction, initiated by Dawex, Fraunhofer ISST and TNO, is a critical milestone to align stakeholders behind a common normative baseline that will help accelerate data exchanges across organizations, industries and geographies,” says Fabrice Tocco, Dawex co-CEO. “As other organizations join the initiative, the outcomes resulting from the collective work will serve all the use cases where stakeholders need to establish trust for the purpose of data exchange and interconnection of data spaces.”
“We are looking forward to actively engaging as co-proposer in the Trusted Data Transaction pre-standardization program, initiated by Fraunhofer ISST, Dawex and TNO. This structuring program will provide guiding principles to organizations looking at building strong data spaces in a trustworthy data economy,” said Prof. Dr.-Ing. Boris Otto, Chairman of the Fraunhofer ICT Group and Executive Director of the Fraunhofer Institute for Software and Systems Engineering ISST.
Berry Vetjens, Managing Director a.i. ICT, Strategy and Policy at TNO, added: “The Trusted Data Transaction pre-standardization workshop program will be useful to support the development of standards and contribute to the activities of European initiatives such as the Data Space Support Center by proposing a common ground to refer to.”
About Dawex
In today’s economy where data has become a product of unlimited potential, with its own value, and a source of new revenue streams, Dawex technology allows organizations to create new ecosystems around data exchange platforms that meet regulatory requirements and address traceability and security challenges. Dawex is the leading technology company for data exchange, data marketplace and data hub to orchestrate the sourcing, the distribution and the exchange of data. Awarded Technology Pioneer by the World Economic Forum in 2020, Dawex is an active member of Gaia-X. Created in 2015, Dawex is headquartered in France, expanding business operations to Europe, Asia, North America and the Middle East.
About Fraunhofer
The Fraunhofer-Gesellschaft based in Germany is the world’s leading applied research organization. Prioritizing key future-relevant technologies and commercializing its findings in business and industry, it plays a major role in the innovation process. A trailblazer and trendsetter in innovative developments and research excellence, it is helping shape our society and our future. Founded in 1949, the Fraunhofer-Gesellschaft currently operates 76 institutes and research units throughout Germany. Over 30,000 employees, predominantly scientists and engineers, work with an annual research budget of €2.9 billion. Fraunhofer generates €2.5 billion of this from contract research.
About TNO
TNO is the independent organization for applied research, based in The Netherlands. We connect people and knowledge to create innovations that sustainably strengthen the competitiveness of companies and the well-being of society. Our goal is to connect, change and accelerate: Innovation for life.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230208005029/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Stafford Establishes Timberland Continuation Fund at USD 1.2 billion4.12.2025 10:53:00 CET | Press release
This marks Stafford’s second timberland fund at over USD 1 Billion in 2025, backed by strong existing investor support and new capital commitments from global institutional investors Stafford Capital Partners (“Stafford”) today announced it has established a USD 1.2 billion continuation vehicle, the Stafford International Timberland Continuation Fund (The Continuation Fund or The Fund), marking a significant milestone in the firm’s strategic management of its timberland holdings. The Continuation Fund is a "roll-up" of three of Stafford’s existing core timberland funds – Stafford International Timberland funds VI, VII and VIII – into a new perpetual fund that will hold 74 high-quality core timberland assets. The fully-deployed portfolio took Stafford seven years to construct and holds interests in over 6.3m acres of commercial timberland in the USA, New Zealand, Australia and Latin America. This includes a number of assets that are seen as key strategic holdings in these regions where
Smartstream Introduces Agentic AI ‘Smart Agents’ for Investigations and Exceptions Handling4.12.2025 09:55:00 CET | Press release
Smartstream, the trusted data solutions provider for leading global financial institutions and enterprises, today announces the preview of Smart Agents for Investigations, a breakthrough in financial operations that brings augmented and autonomous exception handling to reconciliations and back-office processes. The new investigation agent combines domain-trained AI agents, workflow adoption, and embedded controls to triage, investigate, resolve, and learn from exceptions - reducing manual effort, accelerating time to resolution, and strengthening auditability. It will add a layer of intelligence on top of Smartstream’s current reconciliations and exceptions solutions. It understands the breaks context, adheres to customer playbooks and reaches out for missing information. It documents every step for audit and compliance, allowing analysts to focus on risk. Finally, it augments the analyst’s investigation with contextual information radically changing the user experience to review and a
LabGenius Therapeutics Announces New Collaboration with Sanofi for Multiple AI/ML-driven Antibody Optimisation Programmes4.12.2025 09:00:00 CET | Press release
The companies have entered into a new collaboration where LabGenius Therapeutics will apply its ML-driven antibody discovery platform (EVA™) to optimise potential therapeutic NANOBODY® proteins for multiple new targets LabGenius Therapeutics (“LabGenius”), a drug discovery company combining machine learning (ML) and high-throughput experimentation to optimise potential therapeutic antibodies, today announced a second collaboration with Sanofi. This collaboration combines LabGenius’ AI/ML-driven antibody design capabilities with Sanofi’s expertise in the development of therapeutic NANOBODY® molecules to co-optimise proteins for therapeutically valuable properties. Following the success of their first collaboration, LabGenius will apply the EVA™ platform to optimise NANOBODY® molecules for multiple new targets in the area of inflammation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251204759388/en/ “We are truly excited abo
GoWit One: The Unified AI Operating System Set to Revolutionize Commerce & Retail Media4.12.2025 07:09:00 CET | Press release
WPP Turkey has been selected as a pilot partner to deploy GoWit One, cutting campaign setup time to 10 minutes. GoWit, a global AdTech leader in omnichannel Commerce and Retail Media, announced the launch of GoWit One, the unified AI operating system that brings automation, unification, and real-time intelligence into a single ad platform for agencies operating across multiple retailers, channels, and markets. By bringing these three elements into one dashboard, GoWit One addresses the industry's most critical bottleneck: operational inefficiency. The platform enables agencies to manage campaigns across multiple retailers, channels, and markets, reducing manual AdOps workflows by 98%, turning a process that used to take hours into as little as 10 minutes. Solving the “Fragmentation Crisis” Despite the explosive growth of Retail Media, the industry faces a significant hurdle. According to the IAB, 70% of the market still lacks end-to-end AI adoption. Media buyers are currently forced to
Galderma Secures ‘BBB’ Credit Rating With Positive Outlook from S&P Global Ratings4.12.2025 07:00:00 CET | Press release
‘BBB’ long-term issuer credit rating from S&P Global RatingsPositive outlook, reflecting expected profitability improvement, ramp up of Nemluvio, and continued deleveraging and balance sheet improvementRecognition of Galderma’s science-based dermatology portfolio and global operations Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that S&P Global Ratings (S&P) has assigned the company a ‘BBB’ long-term issuer credit rating with a positive outlook. The rating reflects Galderma’s strong track record of growth and its leading positions across Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. S&P notes the company’s well-established brand portfolio, global footprint, including an expanding presence in emerging markets, and continued investment in science-based innovation. S&P highlights momentum from recent launches, including Nemluvio® (nemolizumab), alongside improving profitability and expanding free operating cash flow
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
